KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Vertex Pharmaceuticals (VRTX) Equity Ratio (2016 - 2025)

Vertex Pharmaceuticals has reported Equity Ratio over the past 17 years, most recently at 0.73 for Q4 2025.

  • Quarterly results put Equity Ratio at 0.73 for Q4 2025, changed 0.05% from a year ago — trailing twelve months through Dec 2025 was 0.73 (changed 0.05% YoY), and the annual figure for FY2025 was 0.73, changed 0.05%.
  • Equity Ratio for Q4 2025 was 0.73 at Vertex Pharmaceuticals, up from 0.7 in the prior quarter.
  • Over the last five years, Equity Ratio for VRTX hit a ceiling of 0.78 in Q3 2022 and a floor of 0.7 in Q3 2025.
  • Median Equity Ratio over the past 5 years was 0.75 (2021), compared with a mean of 0.75.
  • Biggest five-year swings in Equity Ratio: grew 4.95% in 2021 and later fell 7.53% in 2024.
  • Vertex Pharmaceuticals' Equity Ratio stood at 0.75 in 2021, then grew by 1.94% to 0.77 in 2022, then grew by 0.9% to 0.77 in 2023, then decreased by 5.84% to 0.73 in 2024, then dropped by 0.05% to 0.73 in 2025.
  • The last three reported values for Equity Ratio were 0.73 (Q4 2025), 0.7 (Q3 2025), and 0.71 (Q2 2025) per Business Quant data.